Bristol Myers Squibb (NYSE: BMY) is scheduled to report its Q2 2022 results on Wednesday, July 27. We expect BMS to report revenue and earnings marginally above the consensus estimates.
Bristol Myers Squibb (NYSE: BMY) is scheduled to report its Q2 2022 results on Wednesday, July 27. We expect BMS to report revenue and earnings marginally above the consensus estimates.
Share this Article
Recommended